Sub-chronic toxicity of gold nanoparticles in male mice

Ajdary, Marziyeh; Ghahnavieh, Marziyeh Ziaee; Naghsh, Nooshin

Sub-chronic toxicity of gold nanoparticles in male mice

Authors

¹ Department of Biology, Payame Noor University, Iran

² Department of Biology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran

Abstract

Background: Gold nanoparticles have many industrial applications; moreover, they are photothermic agents for clinical treatment of cancer. This study was provided to investigate the effects associated with different doses of applied gold nanoparticles by injection and contact procedures on the alterations of the serum levels and certain factors in male mice.
Materials and Methods: 72 male mice were randomly assigned into two protocols in terms of touching and injection. The injection protocol was included of five groups: Sham, control, 25, 50, and 100 ppm. They received gold nanoparticles at 25, 50, and 100 ppm concentrations administered in form of 0.3 ml/day for the period of 14 days and that of touching protocol were received 0.2 ml/day gold nanoparticles. Blood sample of which was taken to measure the serum level of creatine kinase phosphate, fasting blood, creatinine, albumin, blood urea nitrogen and eventually, the kidney was dissected for the intent of pathological analysis.
Results: The serum level of creatine kinase phosphate and fasting blood sugar at middle dose was significantly different (P 0≤ 0.05) in touching protocol. In both protocols, the serum level of creatinine in high and medium doses showed a significant difference (P < 0.05) associated with the treated group. In the touching method, in high and medium doses administered to the treated group, the alteration was significant (P ≤ 0.05). In the both protocols, the serum level of albumin in high and medium doses of the treated group showed significant difference (P < 0.05). Thus, the gold nanoparticles could result in undesirable effects upon kidney tissue.
Conclusion: The result of this study indicated that the administration of gold nanoparticles by touching method was more effective on the serum levels of these factors than that of injection method.

Keywords

References

1.	Kuzma J, Besley JC. Ethics of risk analysis and regulatory review: From bio- to nanotechnology. Nanoethics 2008;2:149-62.
2.	Yang W, Peters JI, Williams RO 3 ^rd . Inhaled nanoparticles--a current review. Int J Pharm 2008;356:239-47.
3.	Bystrzejewska-Piotrowska G, Golimowski J, Urban PL. Nanoparticles: Their potential toxicity, waste and environmental management. Waste Manag 2009;29:2587-95.
4.	Babadi VY, NajafiL, Najafi A, Gholami H, Zarji ME, Golzadeh J, et al. Evaluation of iron oxide nanoparticles effects on tissue and enzymes of liver in rats. J Pharm Biomed Sci 2012;23:1-3.
5.	Higby GJ. Gold in medicine: A review of its use in the West before 1900. GoldBull 1982;15:130-40.
6.	Richards DG, McMillin DL, Mein EA, Nelson CD. Gold and its relationship to neurological/glandular conditions. Int J Neurosci 2002;112:31-53.
7.	Andresen TL, Jensen SS, Kaasgaard T, Jørgensen K. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2. Curr Drug Deliv 2005;2:353-62.
8.	El-Sayed IH, Huang X, El-Sayed MA. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 2006;239:129-35.
9.	Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A 2003;100:13549-54.
10.	Foreback CC, Chu JW. Creatine kinase isoenzymes: Electrophoretic and quantitative measurements. Crit Rev Clin Lab Sci 1981;15:187-230.
11.	Grande P, Christiansen C, Pedersen A,Christensen MS. Optimal diagnosis in acute myocardial infarction. A cost-effectiveness study. Circulation 1980;61:723-8.
12.	Johnston CC, Bolton EC. Cardiac enzymes. Ann Emerg Med 1982;11:27-35.
13.	Desmecht D, Linden A, Amory H, Art T, Lekeux P. Relationship of plasma lactate production to cortisol release following completion of different type of sporting events in horses. Vet Res Commun 1996;20:371-9.
14.	Holemans K, Van Bree R, Verhaeghe J, Meurrens K, Van Assche FA. Maternal semistarvation and streptozotocin-diabetes in rats have different effects on the in vivo glucose uptake by peripheral tissues in their female adult offspring. J Nutr 1997;127:1371-6.
15.	Shakibaie M, Shahverdi AR, Faramarzi MA, Hassanzadeh GR, Rahimi HR, Sabzevari O. Acute and subacute toxicity of novel biogenic selenium nanoparticles in mice. Pharm Biol 2013;51:58-63.
16.	Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: A new X-ray contrast agent.Br J Radiol 2006;79:248-53.
17.	Barathmanikanth S, Kalishwaralal K, Sriram M, Pandian SR, Youn HS, Eom S, et al. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnology 2010;8:16.
18.	Terentyuk G, Akchurin G, Maksimova I, Shantrokha A, Tuchin V, Maslyakova G, et al. Tracking gold nanoparticles in the body. SPIE Newsroom 2009;10:1-3.
19.	Chen J, Patil S, Seal S, McGinnis JF. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 2006;1:142-50.
20.	Yan G, Huang Y, Bu Q, Lv L, Deng P, Zhou J, et al. Zinc oxide nanoparticles cause nephrotoxicity and kidney metabolism alterations in rats. J Environ Sci Health A Tox Hazard Subst Environ Eng 2012;47:577-88.
21.	Kojouri GA, Sharifi S. Preventing effects of nano-selenium particles on serum concentration of blood urea nitrogen, creatinine, and total protein during intense exercise in donkey. J Equine Vet Sci 2013;33:597-600.
22.	Giri S, Karakoti A, Graham RP, Maguire JL, Reilly CM, Seal S, et al. Nanoceria: A rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer. PLoS One 2013;8:e54578.

Advanced Biomedical Research